Molecular variants of HPV-16 associated with cervical cancer in Indian population

International Journal of Cancer

Volumn 125, Issue 1, 2009, Pages 91-103

  Pillai, M R ^a   Hariharan, R ^a   Babu, Janki Mohan ^a   Lakshmi, S ^b   Chiplunkar, S V ^c,d   Patkar, M ^c,d   Tongaonkar, H ^c,d   Dinshaw, K ^c,d   Jayshree, R S ^e   Reddy, B K M ^e   Siddiqui, M ^f   Roychoudury, Soma ^f   Saha, Baisakhi ^g   Abraham, P ^h   Gnanamony, M ^h   Peedicayil, A ^h   Subhashini, J ^h   Ram, T S ^h   Dey, Bindu ⁱ   Sharma, C ^j   Jain, S K ^j   Singh, N ^j   more..

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b REGIONAL CANCER CENTRE   (India)

^c TATA MEMORIAL HOSPITAL   (India)

^d D Y Patil Medical College   (India)

^e KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^f Cancer Foundation of India   (India)

^g BOSE INSTITUTE   (India)

^h CHRISTIAN MEDICAL COLLEGE   (India)

ⁱ Department of Biotechnology ^*  (India)

^j ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

more..

Author keywords

Cervical cancer; Human papilloma virus 16; Variants

Indexed keywords

CALGRANULIN; EPITOPE; PROTEIN E6; PROTEIN E7; PROTEIN P53; CAPSID PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; B LYMPHOCYTE; DISEASE ASSOCIATION; E6 GENE; E7 GENE; FEMALE; GENE; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INDIAN; L1 GENE; MUTATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; SAMPLING; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS GENE; CLASSIFICATION; CLINICAL TRIAL; GENETICS; INDIA; MIDDLE AGED; MULTICENTER STUDY; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; INDIA; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 66149134832     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24322     Document Type: Article

References (48)

1. Bosch FX, Manos MM, Munoz N, Sharma M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of HPV in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study. Group. J Natl Cancer Inst 1995;87:796-802.
2. Wu Y, Chen Y, Li Y, Yu G, Zhang Y, He Y. Association of high risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006;33:264-9.
3. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
4. Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, zur Hausen H, Luthra UK. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992;36:239-45.
5. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, Rao BN, Devi RR, Gravitt PE, Ramakrishna G. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 2005;5:116-23.
6. Zehbe I, Tommasno M. The biological significance of human papillomavirus type 16 variants for the development of cervical neoplasia. Papillomavirus Rep 1999;10:105-16.
7. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuco G, Piccoli R, Palmieri S, Buonaguro FM. Prevalence of HPV genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agents Cancer 2007;2:1-9.
8. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
9. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 1991;29:1765-72.
10. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-68.
11. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 1995;172:747-55.
12. Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, Batra S, Das BC. Human papillomavirus type 16 variant analysis of E6. E7, and. L1 genes and long control region in biopsy samples from cervical cancer patients in North India. J Clin Microbiol 2008;46:1060-6.
13. Wu Y, Chen Y, Li L, Yu G, He Y, Zhang Y. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 2006;87:1181-8.
14. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6. L2, and L1 coding segments. J Virol 1995;69:7743-53.
15. Kirnbauer R, Taub J, Greenstone H, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 1993;67:6929-36.
16. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001;93:315-18.
17. Matsumoto K, Yasugi T, Nakagawa S, Okubo M, Hirata R, Maeda H, Yoshikawa H, Taketani Y. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 2003;106:919-22.
18. Clifford GM, Smith JS, Plummer M, Mu~noz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer 2003;88:63-73.
19. De Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova ES, Kolkman-Uljee S, Fleuren GJ. Human papillomavirus type 16 E6. E7 and. L1 variants in cervical cancer in Indonesia. Surinam, The. Netherlands. Gynecol Oncol 2004;94:488-94.
20. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutsky LA. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst 2006;98:1045-52.
21. Radhakrishna Pillai M, Sreevidya S, Pollock BH, Jayaprakash PG, Herman B. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 2002;87:268-73.
22. Sathish N, Abraham P, Peedicayil A, Sridharan G, Chandy G. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett 2005;229:93-9.
23. Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006;118:1071-6.
24. Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 2006;15:820-2.
25. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69:364-8.
26. Xi LF, Koustsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:796-802.
27. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001;94:711-16.
28. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 2006;350:216-27.
29. Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I. Human papillomavirus 16 E6. L1, L2 and. E2 gene variants in cervical lesion progression. Virus Res 2008;131:106-10.
30. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998;58:829-33.
31. Hu X, Guo Z, Tianyun P, Pontén F, Wilander E, Andersson S, Pontén J. HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int J Cancer 1999;83:34-7.
32. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998;78:166-71.
33. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS, Stern PL. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1995;1:464-70.
34. Brady CS, Duggan-Keen MF, Davidson JA, Varley JM, Stern PL. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J Gen Virol 1999;80:3233-40.
35. Conrad-Stöppler MC, Ching K, Stöppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996;70:6987-93.
36. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
37. Fujinaga Y, Okazawa K, Nishikawa A, Yamakawa Y, Fukushima M, Kato I, Fujinaga K. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 1994;9:85-92.
38. Eschle D, Dürst M, ter Meulen J, Luande J, Eberhardt HC, Pawlita M, Gissmann L. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 1992;73:1829-32.
39. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 1997;66:275-81.
40. Kämmer C, Tommasino M, Syrjänen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 2002;86:269-73.
41. Smahel M, Tejklova P, Smahelova J, Polakova I, Mackova J. Mutation in the immunodominant epitope of HPV 16 E7 oncoprotein as a mechanism of tumor escape. Cancer. Immunology. Immunotherapy. 2008;57:823-31.
42. Müller M, Zhou J, Reed TD, Rittmüller C, Burger A, Gabelsberger J, Braspenning J, Gissmann L. Chimeric papillomavirus-like particles. Virology 1997;234:93-111.
43. Tan W, Felber BK, Zolotukhin AS, Pavlakis GN, Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J Virol 1995;69:5607-20.
44. Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000;5:557-67.
45. Varsani A, Williamson AL, Jaffer MA, Rybicki EP. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene. Virus Res 2006;122:154-63.
46. Touze A, El Mehdaoui S, Sizaret PY, Mougin C, Mu~noz N, Coursaget P. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol 1998;36:2046-51.
47. Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB. Papillomavirus capsid mutation to escape dendritic cell dependent innate immunity in cervical cancer J Virol 2005;79:6741-50.
48. White WI, Wilson SD, Palmer-Hill FJ, Woods RM, Ghim SJ, Hewitt LA, Goldman DM, Burke SJ, Jenson AB, Koenig S, Suzich JA. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol 1999;73:4882-9.